Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

The Cost of Lung Cancer in Germany

October 2, 2015 8:00 am | by German Research Center for Environmental Health | News | Comments

With more than 50,000 newly diagnosed cases each year, lung cancer is one of the most common types of cancer in Germany. Read more...


Cell Marker Enables Prognosis about Course of Infections

October 2, 2015 7:45 am | by Technical University of Munich | News | Comments

The immune system defends us against pathogens and cancer cells. Read more...

Four Gut Bacteria Decrease Asthma Risk in Infants

October 2, 2015 7:30 am | by University of British Columbia | News | Comments

The researchers confirmed these findings in mice and also discovered that newborn mice inoculated with the FLVR bacteria developed less severe asthma. 


Teva Acquires Mexico-based Drugmaker Rimsa for $2.3B

October 2, 2015 7:15 am | News | Comments

Teva expects to close these transactions by early first quarter, 2016. Read more...


Travel 'Superbugs' Add Infection Risk to Common Procedures

October 2, 2015 7:00 am | by University of Queensland | News | Comments

Travelers exposed to antibiotic-resistant bacteria may force a change to common medical procedures that rely on effective antibiotics. Read more...


Scientists Identify Key Receptor as Potential Target for Treatment of Autism

October 1, 2015 10:26 am | by The Scripps Research Institute | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have uncovered a significant--and potentially treatable--relationship between a chemical that helps transmit signals in the brain and genetic mutations present in a subset of individuals with autism spectrum disorder. Read more...


Report: Glucose Monitoring Market tops $10 Billion

October 1, 2015 10:22 am | News | Comments

The global glucose monitoring device and diabetes management market is valued at $10,025 billion for 2015. So says a new report on the industry from Kalorama Information.  Read more...


BMS Receives FDA Approval for Opdivo + Yervoy Regimen in Metastatic Melanoma

October 1, 2015 10:18 am | News | Comments

Bristol-Myers Squibb Company today announced that the U.S. Food and Drug Administration (FDA) approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab), for the treatment of patients with BRAF V600 wild-type unresectable or metastatic melanoma. Read more...


Low-Nicotine Cigarettes Cut Use, Dependence, Study Finds

October 1, 2015 10:13 am | by Marilynn Marchione, AP Medical Writer | News | Comments

A new study might help the push for regulations to limit nicotine in cigarettes. Smokers who switched to special low-nicotine ones wound up smoking less and were more likely to try to quit, researchers found. Read more...


Novartis: Secukinumab Phase 3 Data Confirms Efficacy in Patients with Psoriatic Arthritis

October 1, 2015 10:09 am | News | Comments

Novartis announced today that results from the pivotal Phase 3 FUTURE 1 study for secukinumab in psoriatic arthritis (PsA) were published online in The New England Journal of Medicine (NEJM). Secukinumab is the first interleukin-17A (IL-17A) antagonist to demonstrate efficacy in a Phase 3 study in patients with active PsA, a painful, debilitating condition causing inflammation of joints and skin. Read more..


Rare Q Fever Outbreak Reported in American Medical Tourists

October 1, 2015 10:05 am | by Mike Stobbe, AP Medical Writer | News | Comments

Five Americans came down with an unusual illness after traveling to Germany for a controversial treatment involving injections with sheep cells, health officials reported Wednesday. Read more...


FDA Grants Priority Review to Jazz Pharmaceutical's VOD Drug

October 1, 2015 8:00 am | News | Comments

Priority Review status is designated for drugs that may offer major advances in treatment or provide a treatment where no adequate therapy exists. Read more...


PAH Treatment Space Boosted by Combination Therapies

October 1, 2015 7:55 am | by Lakshmi Dharmarajan, Ph.D, Senior Cardiovascular and Metabolic Disorders Analyst, GlobalData | News | Comments

The increased use and higher cost of combination therapy for pulmonary arterial hypertension will enhance treatment outcomes and bolster market growth. Read more...


Antipsychotics Increase Death Risk for People with Parkinson's Disease Psychosis

October 1, 2015 7:45 am | by King's College London | News | Comments

Antipsychotic drugs may increase the risk of death in people with Parkinson's disease psychosis. Read more...

Genes that Protect African Children from Developing Malaria Identified

October 1, 2015 7:40 am | by University of Oxford | News | Comments

Researchers can be sure that this particular stretch of our DNA plays a crucial role in the progression of the disease. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.